CancerIQ
canceriq.com
Actively hiring
Care Coordination & Population Health
Clinical Decision Support
As featured in
View 1 job
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$15.6M
3 rounds on record
Latest round
$14M
Venture round · Mar 2022 · 4 yr ago
Team
27
US Form 5500 (plan participants) · Dec 2025 · -21% in a year
Hiring now
2
+1 posted in 30 days
Backers
2
Cleveland Avenue, HealthX Ventures
The money's age
Long since its last round
54 months since the last round · and hiring
Momentum
28/100
hiring for its size, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Team shrank to 27 was 34 · US Form 5500 (plan participants)
Aug 27, 2025
Launched CancerIQ rolls out new platform features to help patients act on their cancer risk · fiercehealthcare.com
Nov 1, 2023
Took on debt financing $4.3M · SEC Form D
Mar 3, 2022
Raised a round Venture round $14M · led by Merck Global Health Innovation Fund · MedCity News
Feb 27, 2020
Raised a round Venture round $1.6M · SEC Form D
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Nov 2023 | $4.3M | — | SEC Form D |
| Venture round | Mar 2022 | $14M | Merck Global Health Innovation Fund lead, Amgen Ventures lead | MedCity News |
| Venture round | Feb 2020 | $1.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Cancer IQ Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Christopher BunExecutive OfficerSEC Form D
Haibo LuExecutive Officer, DirectorSEC Form D
Olufeyikemi AyodeleExecutive Officer, DirectorSEC Form D
Paul BurtonExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Cleveland Avenue 
HealthX Ventures Similar startupsby what they do, their industry and backers
Can AI Predict Breast Cancer Risk? Yes.. Identify individuals that will benefit the most from supplemental screening.
Senseye is building the breakthrough diagnostic platform for mental health — and we're starting with PTSD.. We aim to help clinicians…
Regard is a clinical artificial intelligence company whose software reads a patient's full chart and suggests diagnoses that clinicians may…
Bayesian monitors every patient continuously, surfaces only those who need attention, and gives clinicians the guidance to act —…
At OncoveryCare, our goal is to get every cancer survivor back to health, back to work, and back to life. Because survivorship can be hard…
AI-powered clinical intelligence that helps clinicians deliver more complete, patient-centered care. Unlock $35-100K per clinician in…
News
Eon, CancerIQ Partner to Find At-Risk Patients Earlier and Drive Completion of Recommended Care
/PRNewswire/ -- Eon, a leader in incidental findings and early detection technology, today announced a partnership with CancerIQ, a cancer risk identification...
Read more
Report
CancerIQ Expands Diagnostic Network with Addition of geneType PRS Test from Rhythm Biosciences
/PRNewswire/ -- CancerIQ today announced that the geneType Cancer Risk Assessment from Rhythm Biosciences is now available on the CancerIQ platform, expanding...
Read more
Report
CancerIQ Launches Research Initiative to Quantify Downstream Value of Digitally Enabled Cancer Risk Programs
/PRNewswire-PRWeb/ -- CancerIQ, a best-in-class cancer-focused precision health platform, today announced it is seeking health systems to participate in the...
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Christopher Bun
Executive Officer
Haibo Lu
Executive Officer, Director
Olufeyikemi Ayodele
Executive Officer, Director
Paul Burton
Executive Officer
Jordan Dolin
Director
Evan Wood
Director
Olufunmilayo Olapade
Director
Mark Bakken
Director
Andrea Metkus
Director
Joel Krikston
Director
Carladenise Edwards
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
53/100
Stable
Open positions
2
1 opened / 0 closed in 30 days
ATS activity
Every ~6 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Product
100% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Chicago
Jobs
≈ $118k – $214k per year (Estimated) • In office • Full-Time • Bachelor's Degree • Chicago
Apply